The study was undertaken to examine visual pathway function by psycho- and electrophysiological studies in patients with type 1 diabetes. Sixty-three patients (age 25±2.3 years) with moderate type 1 diabetes in a subcompensated state (mean HbA1c 7.4±0.2%), including 32 patients without diabetic retinopathy (DR) and 31 patients with nonproliferative diabetic retinopathy were examined. A control group consisted of 30 healthy individuals. The complex of diagnosis included critical flicker frequency test, retinal light and contrast sensitivity threshold tests, electroretmography (ERG), and studies of optic nerve lability and visual evoked potentials (VEP). A comprehensive study established functional visual pathway abnormalities that were undetectable on routine ophthalmologlcal examination. Lower ERG "a" wave amplitudes, higher latency, and reductions in the amplitude of VEP P100 peak and in spatial contrast sensitivity for low frequencies were of the greatest value in the diagnosis of diabetic abnormalities of the visual pathway. Visual pathway lesions are detectable in patients with type 1 diabetes without DR. In the latter, these lesions are more pronounced.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.14341/probl20075333-7 | DOI Listing |
Purpose Of Review: Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment and trauma, posing significant challenges to surgical success and visual prognosis. Despite advancements in vitreoretinal surgery, PVR incidence remains unchanged, this review presents a synthesis of the principal clinical and preclinical research findings from recent years.
Recent Findings: Recent research has focused on anti-inflammatory, antiproliferative, and antifibrotic agents.
Front Aging Neurosci
January 2025
Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Purpose: Differentiating between Alzheimer's disease (AD) and frontotemporal dementia (FTD) can be challenging due to overlapping cognitive and behavioral manifestations. Evidence regarding non-invasive and early-stage biomarkers remains limited. Our aim was to identify retinal biomarkers for the risk of AD and FTD in populations without dementia and explore underlying brain structural mechanisms.
View Article and Find Full Text PDFGamma oscillations are disrupted in various neurological disorders, including Alzheimer's disease (AD). In AD mouse models, non-invasive audiovisual stimulation (AuViS) at 40 Hz enhances gamma oscillations, clears amyloid-beta, and improves cognition. We investigated mechanisms of circuit remodeling underlying these restorative effects by leveraging the sensitivity of hippocampal neurogenesis to activity in middle-aged wild-type mice.
View Article and Find Full Text PDFFront Nutr
January 2025
Research Institute, Suntory Global Innovation Center Ltd., Kyoto, Japan.
Introduction: The brain uses ketones, mainly 3-hydroxybutyrate (3-HB), as an alternative energy source. Therefore, oral intake of 3-HB may help maintain brain health. Previous studies indicated that achieving a maximum concentration (C) of 3-HB in plasma at 0.
View Article and Find Full Text PDFEnviron Manage
January 2025
TECNALIA Research & Innovation, Basque Research and Technology Alliance (BRTA), Energy, climate, and urban transition, Parque Tecnológico de Bizkaia, Derio, Spain.
The extent and timescale of climate change impacts remain uncertain, including global temperature increase, sea level rise, and more frequent and intense extreme events. Uncertainties are compounded by cascading effects. Nevertheless, decision-makers must take action.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!